Peter C. De Bruin

Nieuwegein, UT 3435CM, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction: Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Correction: Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Journal: World journal of urology

Published: September 21, 2023

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital.

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital.

Journal: Cancers

Published: August 20, 2023

Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Journal: World journal of urology

Published: December 21, 2022

Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial.

Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial.

Journal: BJU international

Published: August 22, 2022

Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.

Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.

Journal: Leukemia & lymphoma

Published: December 28, 2021

Discrepancies in digital hematopathology diagnoses for consultation and expert panel analysis.

Discrepancies in digital hematopathology diagnoses for consultation and expert panel analysis.

Journal: Virchows Archiv : an international journal of pathology

Published: December 06, 2019

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: December 04, 2019

Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer.

Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer.

Journal: The Journal of urology

Published: September 06, 2019

Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?

Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?

Journal: European urology oncology

Published: April 15, 2019

The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.

The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.

Journal: European urology

Published: September 11, 2018

Molecular clonality assessment shows high performance to predict malignant B-cell non-Hodgkin's lymphoma using cytological smears.

Molecular clonality assessment shows high performance to predict malignant B-cell non-Hodgkin's lymphoma using cytological smears.

Journal: Journal of clinical pathology

Published: March 23, 2016

Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.

Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: March 12, 2014

Showing 1-12 of 24

Last Updated: 09/26/2026